Chocolate La Boulange Soft Caramel, Net WT. 8.4 oz. (238 g); Cooked in small batches in copper pots; all natural La Boulange South...
⚠ Critical Alert — Stop Using Immediately
This product has been flagged with severe risks (undeclared allergen). Stop using it now and contact the brand or FDA for a refund, repair, or replacement.
FDA Recall Notice
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0730-2014.
Firm discovered that 8.4 oz. jars of Hazelnut Jam were produced on 8/15/13 and were mislabeled as La Boulange Soft Caramel. the Hazelnut jam contains hazelnuts which were undeclared on the label.
Corrective Action (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0730-2014.
Recall terminated by FDA.
✅ What you should do
- Stop using the product if you own it.
- Check the model number, lot code, or sell-by date against the recall notice above.
- Contact The New French Bakery or the retailer where you bought it for a refund, replacement, or repair.
- For the most current official instructions, visit the FDA recall page.
- If you've been hurt by this product, report the incident to FDA.
Consumer Contact (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0730-2014.
The New French Bakery
About the U.S. Food and Drug Administration
The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.
Visit FDA.gov →📣 Report a food, supplement, or cosmetic problem to the FDA
If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.
The New French Bakery Recall FAQ
The New French Bakery is the subject of a snacks & candy safety report: Chocolate La Boulange Soft Caramel, Net WT. 8.4 oz. (238 g); Cooked in small batches in copper pots; all natural La Boulange South.... The notice was published on November 13, 2013 by the U.S. Food and Drug Administration (FDA). Approximately 91 units are potentially affected.